You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis

Article metrics

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Research
Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 20181008845
Feb 20181077038
Mar 20181148641
Apr 20181088235
May 2018956547
Jun 2018514728
Jul 2018685426
Aug 2018855843
Sep 2018937535
Oct 201816514355
Nov 201812110344
Dec 201812310326
Jan 201911210741
Feb 20191259228
Mar 2019806235
Apr 2019775334
May 20191057941
Jun 2019856150
Jul 2019947436
Aug 20191024129
Oct 2019867229
Nov 2019825231
Dec 2019906620
Jan 2020804843
Feb 2020865632
Mar 2020644225
May 2020755940
Jun 2020523226
Jul 2020664246
Aug 2020664238
Sep 20201086949
Oct 2020875774
Nov 20201248751
Dec 2020946632
Jan 2021744432
Feb 2021514116
Mar 2021604425
Apr 20211159745
May 2021867537
Jun 2021727336
Jul 2021525222
Aug 2021606523
Sep 2021636287
Oct 2021655252
Nov 2021382834
Dec 2021737123
Jan 202211110031
Feb 2022865631
Mar 20221149441
Apr 20221158829
May 202212611047
Jun 2022868539
Jul 20221038824
Aug 2022918554
Sep 20221048772
Oct 2022946829
Nov 2022998532
Dec 2022877023
Jan 202311610427
Feb 202317816866
Mar 202312311731
Apr 20231139535
May 20231058235
Jun 202311010229
Jul 2023736348
Aug 2023675127
Sep 2023998822
Oct 2023968033
Nov 202312912039
Dec 202313010928
Jan 2024737082
Feb 2024725739
Mar 20241028955
Apr 2024815324
Total686255012797